Adoptive immunotherapy with autologous cytotoxic T lymphocytes (CTLs) pulsed ex vivo with patient-derived tumor cells in heavily pretreated, advanced renal cell carcinoma (aRCC) patients: A feasibility study.

Camillo Porta,Daniela Montagna,Chiara Paglino,Simona Secondino,Cristina Bregant,Carlo Ganini,Cesare Perotti,Ilaria Turin,Paolo Pedrazzoli

Adoptive immunotherapy with autologous cytotoxic T lymphocytes (CTLs) pulsed ex vivo with patient-derived tumor cells in heavily pretreated, advanced renal cell carcinoma (aRCC) patients: A feasibility study.

2017

Camillo Porta
Daniela Montagna
Chiara Paglino
Simona Secondino
Cristina Bregant
Carlo Ganini
Cesare Perotti
Ilaria Turin
Paolo Pedrazzoli

4575 Background: Immunotherapy still remains the only treatment which proved able to induce long-lasting complete responses in aRCC. The aim of the present study was to evaluate the feasibility and...

Keywords:

Cytotoxic T cell
Renal cell carcinoma
Pathology
Cancer research
Immunotherapy
Ex vivo
Medicine
adoptive immunotherapy
tumor cells

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations